Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Alterations in adolescent brain serotonin (5HT)1A, 5HT2A, and dopamine (D)2 receptor systems in a nonhuman primate model of early life adversity
    Published on 2024-04-26
    1 year ago
  • A large-scale c-Fos brain mapping study on extinction of cocaine-primed reinstatement
    Published on 2024-04-25
    1 year ago
  • Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
    Published on 2024-04-24
    1 year ago
  • Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits
    Published on 2024-04-24
    1 year ago
  • Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis
    Published on 2024-04-23
    1 year ago
  • Substance P in the medial amygdala regulates aggressive behaviors in male mice
    Published on 2024-04-22
    1 year ago
  • Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study
    Published on 2024-04-22
    1 year ago
« Previous 1 … 42 43 44 45 46 … 143 Next »
Journal of Psychopharmacology
  • Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants
    Published on 2023-02-04
    2 years ago
  • Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports
    Published on 2023-01-27
    2 years ago
  • The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats
    Published on 2023-01-21
    2 years ago
  • Reduced attentional lapses in male rats following a combination treatment of low-dose D-serine and atomoxetine
    Published on 2023-01-17
    2 years ago
  • A Bayesian meta-analysis of topiramate’s effectiveness for individuals with alcohol use disorder
    Published on 2023-01-17
    2 years ago
  • Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis
    Published on 2023-01-12
    2 years ago
  • Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation
    Published on 2023-01-12
    2 years ago
« Previous 1 … 42 43 44 45 46 … 124 Next »
European Neuropsychopharmacology
  • The direct correlation between Covid-19 and Attention Deficit/Hyperactivity Disorder (ADHD)
    Published on 2023-04-22
    2 years ago
  • Antipsychotic-induced akathisia in adults with acute schizophrenia: A systematic review and dose-response meta-analysis
    Published on 2023-04-18
    2 years ago
  • Impact of antidepressant use on the autonomic nervous system: A meta-analysis and systematic review
    Published on 2023-04-18
    2 years ago
  • The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions
    Published on 2023-04-17
    2 years ago
  • Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data
    Published on 2023-04-14
    2 years ago
  • Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia
    Published on 2023-04-13
    2 years ago
  • Psychotropic drugs consumption during 2020 COVID-19 pandemic and lockdowns: Evidence of a surprising resilience of the drugs delivery system in France.
    Published on 2023-04-11
    2 years ago
« Previous 1 … 42 43 44 45 46 … 144 Next »

   Pharma Pub